We show that acute dietary nitrate supplementation via beetroot juice increases the 44 amplitude and speed of local muscle V̇O 2 on-kinetics parameters during severe-but not 45 moderate-intensity handgrip exercise. These changes were found in the absence of an increased 46 blood flow response, suggesting the increased V̇O 2 was attained via improvements in fractional 47
Abstract 22
Dietary nitrate supplementation has positive effects on mitochondrial and muscle contractile 23 efficiency during large muscle mass exercise in humans, and on skeletal muscle blood flow (Q ) 24 in rats. However, concurrent measurement of these effects has not been performed in humans. 25 Therefore, we assessed the influence of nitrate supplementation on Q and muscle oxygenation 26 characteristics during moderate (40%peak) and severe (85%peak) intensity handgrip exercise in 27 a randomized, double-blind, crossover-design. Nine healthy men (age: 25±2 yrs) completed four 28 constant-power exercise tests (two per intensity) randomly assigned to condition (nitrate-rich 29 (Nitrate) or nitrate-poor (Placebo) beetroot supplementation) and intensity (40%peak or 30 85%peak). Resting mean arterial pressure was lower after Nitrate compared to Placebo (84±4 vs 31 89±4 mmHg; p<0.01). All subjects were able to sustain 10 min of exercise at 40%peak in both 32 conditions. Nitrate had no effect on exercise tolerance during 85%peak (Nitrate: 358±29, 33 Placebo: 341±34 s; p=0.3). Brachial artery Q was not different after Nitrate at rest or any time 34 during exercise. Deoxygenated- [hemoglobin+myoglobin] was not different for 40%peak 35 (p>0.05), but was elevated throughout 85%peak (p<0.05) after Nitrate. The metabolic cost (V̇O 2 ) 36 was not different at end exercise, however, the V̇O 2 primary amplitude at the onset of exercise 37 was elevated after Nitrate for the 85%peak work rate (96±20 vs 72±12 ml/min; p<0.05) and had 38 a faster response. These findings suggest that an acute dose of Nitrate reduces resting blood 39 pressure and speeds V̇O 2 kinetics in young adults, but does not augment Q or reduce steady-state 40 V̇O 2 during small muscle mass handgrip exercise. Dietary nitrate supplementation is well documented to have positive effects during large 51 muscle mass exercise in humans (4, 33, 38, 48, 50) . These effects include lowering oxygen 52 consumption (V̇O 2 ) (4, 32, 38, 42) , speeding V̇O 2 kinetics (3, 6, 31, 32) and reducing the ATP 53 cost of work (2, 26) during submaximal exercise, which may translate to the enhanced exercise 54 tolerance found during severe intensity exercise (6, 31, 37, 50) . The precise mechanism(s) for 55 these effects still remains uncertain, but they are facilitated through the reduction of the dietary 56 nitrate to nitrite by commensal bacteria in the mouth (40) . Once absorbed into the circulatory 57 system, nitrite is readily converted to nitric oxide (NO) in hypoxic (16, 47) and acidic (41) 58 environments, which are expected to be present at the exercising muscle. 59
Nitric oxide is a potent vasodilator (20, 22, 45) ; as such it had been proposed that nitrate 60 supplementation may augment blood flow (Q ) to active muscle. This was first experimentally 61 investigated in rats during submaximal treadmill running (23, 24) . These authors found that 62 nitrate supplementation resulted in an increased Q to the hindlimb, particularly to muscles 63 composed of greater percentages of type II fibers. These findings demonstrate that nitrate may 64 change the regulation of Q relative to V̇̇O 2 , as these two variables generally increase in 65 proportion to one another across a range of exercise intensities (1, 43) . Recently the effect of 66 nitrate on Q was investigated in human subjects (5, 12, 34) , but no change in brachial artery 67 blood flow (Q BA ) was found in healthy, young men and women during light-to-moderate 68 intensity handgrip exercise. These previous studies might not have recruited type II fibers in the 69 younger subjects due to lower intensity exercise, potentially missing the preferential effects of 70 dietary nitrate on higher order fiber types (for review see (30)). It should be noted, two of the 71 aforementioned studies did find improvements in compromised populations (i.e., older adults in 72 hypoxia (12) and 'noncompensators' (5)). 73
Importantly, these previous studies in humans using nitrate (12, 34) , provided no measure 74 of V̇O 2 or fractional O 2 extraction (which can be estimated noninvasively via deoxygenated-75
[hemoglobin + myoglobin] (deoxy-[Hb + Mb]) and used to estimate V̇O 2 ) (7, 18, 19, 35) . 76
Moreover, the measurements were made after fixed durations of moderate intensity submaximal 77 exercise and during the steady state, leaving the effects of nitrate on local muscle V̇O 2 during the 78 exercise onset transient unknown. Since faster V̇O 2 kinetics are associated with a reduction in the 79 O 2 deficit (and thus accumulation of fatigue inducing metabolites), these findings carry important 80 implications for patient populations, such as chronic heart failure (CHF), as accumulating 81 evidence suggests nitrate supplementation may be effective for enhancing quality of life through 82 improvements in exercise and/or daily activity tolerance (21, 25, 51) . 83 Therefore, the purpose of this investigation was to resolve whether acute supplementation 84 of nitrate preferentially provided positive effects in small muscle mass exercise during severe 85 intensity exercise, where type II fibers would be recruited and greater hypoxic and acidic muscle 86 environment exists. Specifically, we tested the hypotheses that with nitrate supplementation 87 compared to placebo: 1) Q BA would be significantly elevated during severe, but not moderate 88 intensity exercise; 2) V̇O 2 would be elevated during severe intensity exercise and display faster 89 kinetics; and 3) tolerance of exercise (T lim ) would be increased during severe intensity exercise. 90 91
Materials and Methods

92
Ten healthy, recreationally active men volunteered for the investigation (mean ± SD: age: 93 25 ± 2 yrs; height: 178 ± 4 cm; body mass: 80 ± 10 kg; BMI: 25 ± 3 kg/m 2 ). All experimental 94 procedures in the present study were approved by the Institutional Review Board at Kansas State 95
University and conformed to the standards set forth by the Declaration of Helsinki. Prior to 96 participation in the study, all subjects were informed of the protocol, any possible health risks, as 97 well as the probable benefits of the study. All subjects provided written informed consent to 98 participate and completed a medical health history questionnaire to ensure absence of any known 99 cardiovascular or metabolic diseases which would preclude them from the study. 100 101
Experimental Protocol 102
All testing sessions were performed on a custom-built, two-handed handgrip ergometer 103 previously described by our laboratory (7, 8) . Briefly, the subjects were seated in an upright 104 position at arm's length from the ergometer with the hands pronated at heart level and directly in 105 front of their torso. All sessions were performed utilizing a 50% duty-cycle (1.5 s contraction, 106 1.5 s relaxation) and fixed 4 cm linear displacement that was maintained via audio cues. All 107 subjects were familiarized with the exercise, audio cues, and duty-cycle prior to the first testing 108 session. During the first visit, subjects performed an incremental test for the determination of 109 peak power (P peak ) starting at 1 Watt (W) and increasing at a rate of 0.5 W·min -1 . The test was 110 performed until volitional exhaustion or after three consecutive contraction cycles in which the 111 subject was unable to maintain the correct tempo or complete full contractions. P peak was 112 recorded as the highest power obtained in which the subjects completed at least 30 s of the stage. 113
The four subsequent visits were randomly assigned to 40 or 85 %P peak (two tests per 114 intensity) and supplemental condition (see Supplementation below; Figure 1 ). The four constant 115 power tests were performed for 10 min or until exhaustion for 40 and 85 %P peak , respectively. 116
The coefficient of variation for tolerance of exercise (T lim ) at 85 %P peak intensity in our 117 laboratory is ~7% (8). All testing sessions were separated by 48 -72 h and subjects were asked 118 to abstain from vigorous activity, food, and caffeine prior to testing for 12, 3, and 2 h, 119 respectively. Upon arrival to the laboratory, the subjects sat quietly for 15 min, after which 120 resting blood pressure measurements and subsequent plasma samples were obtained (See Figure  121 1). All exercise tests were performed at approximately the same time of day (± 1.5 h for each 122 subject) between 1000 and 1500 hours. The exercise testing sessions were randomly assigned to nitrate or placebo beetroot 126 supplementation conditions (one of each per intensity; i.e., nitrate + 40 %P peak and placebo + 40 127 %P peak ), creating a randomized, double-blind, crossover study design. In each condition, the 128 subjects consumed beetroot concentrate (2 x 70 ml providing ~13 mmol nitrate) or nitrate-129 depleted beetroot concentrate placebo (2 x 70 ml providing ~0.006 mmol nitrate; both Beet It 130 Sport, James White Drinks, Ipswich, UK). Subjects consumed the shots on their own outside of 131 the laboratory ~2.5 h before testing began to allow for maximal expression of plasma nitrite 132 concentrations ([nitrite]) (49, 50) (See Figure 1 ). This dose of nitrate was chosen because it was 133 shown to increase T lim with no greater effects seen at higher doses (50). During the study, 134 subjects were asked to abstain from using mouthwash (29) and toothpaste or chewing gum that 135 contained triclosan, as these products serve to reduce the oral bacteria needed to facilitate the 136 conversion of nitrate to nitrite. Each exercise testing session was separated from the others by at 137 least 48 h to allow plasma [nitrite] adequate time to return to pre-supplementation concentrations 138 (50). Subjects were asked to maintain their normal diet with the exception of limiting foods high 139 in nitrate, such as spinach and arugula (39) . No subjects reported taking any multivitamins or 140 anti-oxidant supplements. All subjects self-reported compliance with the supplemental protocol. 141
No subjects reported gastrointestinal discomfort; however, when subjects reported typical 142 symptoms (i.e., beeturia or red stools) they were assured this was a typical side effect of the 143 nitrate supplementation. 144 145
Measurements 146
Venous blood samples (5-6 ml) were separated into 1.5 ml Eppendorf tubes containing 5 147 μl heparin (concentration 1000U/ml) and centrifuged at 3250 rpm at 4 °C for 5 min within 1 min 148 of withdrawal. Plasma samples were then pipetted into separate Eppendorf tubes, flash frozen in 149 liquid nitrogen, and stored at -80 °C until later analysis. 150
The measurements of plasma nitrate and nitrite were performed within 30 min of thawing 151 via chemiluminescence with a NO analyzer (NOA 280i, Sievers Instruments, Boulder, CO, 152 USA). In order to obtain plasma nitrite levels and to avoid potential reduction of nitrate, 153 potassium iodide in acetic acid was used as a reductant. This reductant has the ability to reduce 154 nitrite to NO but is incapable of reducing higher oxides of nitrogen (i.e., nitrate), thus increasing 155 the specificity for nitrite. Plasma nitrate concentrations were obtained using the same apparatus 156 with the stronger reductant vanadium chloride in hydrochloric acid at a temperature of 95 °C. 157
This stronger reductant reduces the sum of all nitrogen oxides with an oxidation state of +2 or 158 higher, which is predominately nitrate (μM), but also includes both nitrite (nM) and nitrosothiols 159 (nM). 160
Resting blood pressure was measured in the left arm using an automated patient monitor 161 (S/5 Light Monitor type F-LM1-03, Datex-Ohmeda General Electric, Finland) which makes use 162 of the oscillometric technique. To increase accuracy, this machine utilizes a 3-lead ECG to 163 monitor heart rate. This measurement was taken in triplicate and a mean value was obtained. 164
Exercising blood pressure was taken from the left ankle using the same patient monitor while the 165 subject was seated at the handgrip ergometer. During the measurement, subjects were asked to 166 remain still and allow their leg to relax. A correction factor (pressure = measured pressure -167 (distance between the heart and ankle in meters x 76 mm Hg) was used to adjust for the 168 increased hydrostatic pressure present between the ankle and heart (27). Pilot work performed in 169 our lab validated the correction factor with measurements taken from the ankle and arm at heart 170 level. This pilot work also revealed that the increase in blood pressure during 85 %P peak handgrip 171 exercise exceeded the capabilities of the equipment to accurately measure ankle pressure so 172 pressure was only obtained for the 40 %P peak intensity. 173
The raw blood velocity profiles were measured in the right brachial artery using Doppler 174 ultrasound (Vivid 3, GE Medical Systems, Milwaukee, WI, USA) operating in pulse wave mode 175 at a Doppler frequency of 4.0 MHz with a phased linear array transducer probe operating at an 176 imaging frequency of 6.7 MHz, and were stored for post-hoc analysis. For all testing sessions the 177 Doppler gate was set to the full width of the brachial artery to ensure complete insonation and all 178 Doppler velocity measurements were corrected for the angle of insonation, which was adjusted 179 to be less than 60°. Measurements were made at least 3 cm above the antecubital fossa to avoid 180 bifurcation of the brachial artery. Brachial artery diameters were measured in the transverse axis 181 using two-dimensional sonography. 182
Muscle and microvascular oxygenation status were measured noninvasively using a 183 frequency-domain multi-distance near infrared spectroscopy (NIRS) system (OxiplexTS, ISS, 184 Champaign, IL, USA) positioned over the belly of the left flexor digitorum superficialis (FDS). 185
Details of this technique have been described previously (7, 11 The V̇O 2 (ml O 2 ·min -1 ) of the FDS was calculated for each minute of exercise using the 197 technique described previously (7) values. This calculation was performed with the understanding that Q BA likely overestimates Q 209 through the capillaries under the NIRS probe. However, because the same calculation (and 210 subsequent assumptions) was used across subjects and the primary comparison was within 211 subjects, the error associated with this assumption was minimized. Further, these assumptions 212 were held constant across both supplemental conditions. 213 214
Data analysis 215
Mean blood velocity (V̇m ean ; cm·s -1 ) was defined as the time-averaged mean velocity over 216 each 3 s contraction cycle. Q BA (ml·min -1 ) was calculated using the product of V̇m ean and vessel 217 cross-sectional area (CSA = πr 2 ). CSA (cm 2 ) was calculated each minute of exercise using 218 brachial artery diameters measured at the beginning of each minute. The Q BA data were analyzed 219 using three consecutive contraction cycles (i.e., 9 s) for rest and at the end of each minute of 220 exercise. The NIRS data were first multiplied by 4 to convert the values from hemoglobin 221 equivalents back to total heme units (15) and were subsequently analyzed using 1 s mean values 222 that were converted to 30 s mean bins for resting values and 9 s time-binned mean values at the 223 end of each minute of exercise and at exhaustion. Systolic blood pressure (SBP) and diastolic 224 blood pressure (DBP) were measured at least three times at rest and once every 2 min during 225 exercise and were then used to calculate MAP. Vascular conductance (VC) (ml·min -1 ·(100 226 mmHg) -1 ) was calculated using the quotient of Q BA /MAP, multiplied by 100. 227
Kinetics analyses were conducted for the V̇O 2 data using 6 s time-binned mean values 228 over the initial 120 s of exercise and 9 s time-binned mean values at 180 and 240 s with a mono-229 exponential model: 230
where y(t) is the V̇O 2 at any point in time, y(b) is the baseline before the onset of exercise, A is 232 the primary amplitude of the response, TD is the time delay proceeding the increase in, and τ is 
Results
250
Ten subjects completed the protocol. One subject was determined to be an outlier based 251 on their 85 %P peak T lim change score (-285 s) being more than 3 SD outside the group mean 252 change score ( [nitrite] after acute nitrate supplementation (456 ± 60 vs 68 ± 7 nM, p < 0.001, Fig. 2 ) resulting 259 in a 5.7-fold increase over placebo. Resting blood pressure values are presented in Table 1 . 260
Acute nitrate supplementation was associated with a lowering of SBP, DBP, and MAP by 7%, 261 4%, and 6%, respectively (all p < 0.05) compared to placebo. 262 263 40 %P peak exercise 264
The mean power for 40 %P peak was 2.2 ± 0.1 W. All subjects were able to sustain 10 min 265 of exercise at 40 %P peak in both conditions. Q BA increased rapidly from exercise onset in both 266 conditions before approaching a steady-state of approximately 260 ml·min -1 by 240 s. Q BA was 267 not different after nitrate supplementation at rest or at any time during exercise compared to 268 placebo (Fig. 3) . MAP was measured during exercise in eight of nine subjects. There was no 269 main effect of nitrate on MAP during exercise compared to placebo (p = 0.11, Fig. 4 ), although 270 MAP was 4 mmHg lower on average throughout exercise before reaching the peak values 90 ± 4 271 and 98 ± 5 mmHg (p = 0.02) for nitrate and placebo, respectively. There was no effect of nitrate 272 on VC (p = 0.14, Fig. 4) ; both groups increased to end exercise values of 314 ± 58 and 279 ± 28 273 ml/min/100 mmHg (p = 0.08) for nitrate and placebo, respectively. 274
Deoxy-[Hb + Mb] increased following exercise onset in both conditions, with no 275 differences between conditions. End exercise deoxy-[Hb + Mb] was not different between nitrate 276 and placebo (154 ± 15 vs 156 ± 19 μM, p = 0.83, Fig. 5 ). Total-[Hb + Mb] was not different after 277 nitrate supplementation at any min during exercise or at the end of exercise compared to placebo 278 (408 ± 15 vs 402 ± 25 μM, p = 0.76, Fig. 5 ). V̇O 2 was not different at any min during exercise or 279 at the end of exercise (73.1 ± 16.7 vs 75.8 ± 18.0 ml/min, p = 0.68, Fig. 6 ). The results of the 280 V̇O 2 kinetics analysis are presented in Table 2 (n = 7). 281 282
%P peak exercise 283
The mean power for 85 %P peak was 4.7 ± 0.2 W. Nitrate had no effect on T lim compared 284 to placebo (358 ± 29 vs 341 ± 34 s, p = 0.3, Fig. 7 ). Q BA was not different at rest or any time 285 during exercise after nitrate supplementation. Q BA increased at exercise onset and attained end 286 exercise values of 368 ± 42 and 353 ± 46 ml/min (p = 0.56, Fig. 3 ), for nitrate and placebo, 287 respectively. 288
Deoxy-[Hb + Mb] was not different at rest and increased at exercise onset in both 289 conditions, with nitrate elevated over placebo for time points preceding end exercise (60 -180 s, 290 p < 0.05), but not 240 s (p = 0.08). At T lim , nitrate and placebo were different (203 ± 26 vs 180 ± 291 19 μM, p = 0.03, Fig. 5 ). Total-[Hb + Mb] was not different after nitrate supplementation, both 292 conditions showed a progressive increase toward the end exercise values (447 ± 30 vs 440 ± 31 293 μM, p = 0.65). V̇O 2 increased 897 ± 183% and 838 ± 191% (p = 0.83) from rest to T lim for nitrate 294 and placebo, respectively. There was no difference for end exercise V̇O 2 after nitrate 295 supplementation (112 ± 12 vs 107 ± 14 ml/min, p = 0.62, Fig. 6 ). The results of the V̇O 2 kinetics 296 analysis are presented in Table 2 (n = 7). Both supplemental conditions had significantly higher 297 primary amplitudes during 85% P peak compared to 40% P peak (p < 0.05). Nitrate supplementation 298 also increased the primary amplitude within 85% P peak (p = 0.02) and reduced the time constant 299 (τ; p = 0.04) compared to placebo. 300 301
Discussion
302
The present study investigated the effects of acute nitrate supplementation on conduit 303 artery Q concurrently with local muscle microvascular oxygenation characteristics during 304 moderate and severe intensity handgrip exercise. The acute dosage utilized (~13 mmol nitrate), 305 elevated plasma [nitrite] more than 5-fold higher than that seen with placebo and was associated 306 with reductions in blood pressure at rest of 4-8%. Contrary to our first hypothesis, nitrate had no 307 effect on Q BA at rest or any time point during moderate or severe intensity handgrip exercise 308 compared to placebo. The primary novel finding of the present study, in agreement with our 309 second hypothesis, was that the V̇O 2 primary amplitude was elevated and the kinetics were faster 310 after nitrate during severe intensity handgrip exercise consequent to an increased O 2 extraction 311 (deoxy-[Hb + Mb]) . Additionally, nitrate had no effect on T lim when exercise was performed in 312 the severe intensity domain. 313 314
Effect on control of blood flow 315
Ferguson and colleagues (23, 24) discovered that nitrate supplementation increased bulk 316 hindlimb Q in rats with the largest effect in muscles composed of a high percentage of type IIb 317 and IIx fibers (23, 24) . To date, the previous studies (5, 12, 34) and the present investigation that 318 directly measured Q in young healthy humans during small muscle mass (handgrip) exercise, 319 have been unable to replicate the findings of Ferguson et al. (23, 24) or Cosby et al. (14) . The 320 work of Kim and colleagues (34) had young healthy subjects perform rhythmic exercise under 321 both nitrate and placebo conditions; however the work done was performed at fairly low work 322 rates. The greatest Q BA achieved in the work of Kim et al. (34) was approximately 200 ml/min 323 for both supplementations, which was lower than the Q BA measured in the present investigation 324 at 40 %P peak (~260 ml/min). If dietary nitrate does in fact have preferential effects in high order 325
fiber types, it is likely that Kim et al. (34) and the lower work rate in the present study did not 326 recruit said fibers. 327
The other two studies (5, 12) and the present investigation performed higher intensity 328 exercise that increased the likelihood of recruiting higher order fibers. However, in agreement 329 with the lower intensity data, nitrate supplementation had no effect on the steady state Q BA in 330 healthy young subjects. The present investigation advanced these previous studies by measuring 331 the dynamic response during the onset of exercise. While there was no difference in the speed of 332 the Q BA adjustment to exercise, there was evidence of improved O 2 delivery within the 333 exercising muscle (see Effect on tissue oxygenation and V̇O 2 below). Casey and colleagues (12) 334 attempted to maximize the stimulus for nitrite conversion to NO (and thus maximize the 335 potential augmentation of Q BA ) by putting their subjects in hypoxia, but there was still no 336 difference between nitrate and placebo. The study by Bentley and colleagues (5) used a 337 hydrostatic challenge to alter O 2 delivery and found no differences in the absolute Q BA following 338 nitrate supplementation. These authors did find there was less attenuation of Q BA induced by the 339 hydrostatic challenge following nitrate, which the authors attributed to an increased 340 compensatory vasodilation (5). The supine exercise model used in these aforementioned studies 341 (5, 12, 34) differed from the present investigation in that our subjects were seated upright with 342 the arms at heart level. It has been shown that the seated posture increases muscle sympathetic 343 activity and reduced central venous pressure compared to the supine posture (9). Since the 344 present findings are largely in agreement with these previous studies (5, 12, 34) and handgrip 345 exercise is not limited by cardiac output, these postural differences were likely inconsequential. 346
Nevertheless, a recent study found that acute nitrate supplementation increased peak 347 cardiac output and V̇O 2 in CHF patients with preserved ejection fraction during a supine peak 348 incremental exercise test (51). This study was not designed to resolve the spatial distribution of 349 the ~10% increase in cardiac output. If nitrate does favorably affect VC and Q to type II fibers, 350 as suggested by Ferguson and colleagues (24) , the increased reliance on type II fibers with CHF, 351 and other diseases (28, 46) supports the notion that nitrate supplementation may be more 352 effective in these populations with O 2 delivery challenges. The discovery that nitrate can increase 353 Q BA in older adults in hypoxia (12) showing ~3-5% reductions in V̇O 2 (2, 4, 37, 42, 48, 50) , and others no change (6, 13, 31, 32) 360 after supplementation. NIRS-derived variables measured concurrently with V̇O 2 paralleled the 361 change in V̇O 2 when it occurred (4, 6). 362
Given the above, attempting to interpret the present findings in the context of whole body 363 exercise is difficult. In the present investigation, deoxy-[Hb + Mb] was elevated after nitrate 364 supplementation throughout severe-, but not moderate-, intensity exercise. Moreover, total-[Hb + 365 Mb] was not impacted by nitrate supplementation during both exercise intensities. Changes in 366 total-[Hb + Mb] from rest to exercise are thought to reflect the change in microvascular 367 hematocrit (17). To the best of our knowledge, the current study is the first to observe an 368 increased primary amplitude, exercising level, and T lim value for deoxy-[Hb + Mb] after nitrate 369 supplementation. It should be noted that Breese et al. (6) reported a higher value on beet root 370 juice across the transition from moderate to severe exercise due to faster kinetics, but no 371 differences in the amplitude or T lim were observed (6). Increased deoxy-[Hb + Mb] relative to 372 unchanged total-[Hb + Mb] (and Q BA ), suggests an increased fractional O 2 extraction. The 50% 373 duty-cycle used in the present investigation has been shown to mechanically constrain Q BA and 374 V̇O 2 during severe intensity handgrip exercise (7), such that the present changes should be 375 viewed as positive and suggest improvements in the microvascular distribution of O 2 rather than 376 a decrease in efficiency. Nitrate may facilitate the delivery of O 2 to regions that were otherwise 377 under perfused in this exercise model. This improved O 2 extraction was manifest in the kinetic 378 response (see discussion below); however, there was no difference in V̇O 2 at the end of exercise 379 after nitrate supplementation in the present investigation. This implies that the efficiency of the 380 work was neither positively nor negatively impacted and the improvements in fractional O 2 381 extraction were likely obscured by the mechanical limitations of the exercise. Future work could 382 usefully attempt to elucidate if there is a 'threshold' type effect of the duty cycle used for the 383 exercise (i.e., employing 20, 30, 40% duty cycles in the severe intensity domain). 384 385 Effect on V̇O 2 kinetics parameters and tolerance to exercise 386
No differences in the end exercise amplitude of local muscle V̇O 2 were found in the 387 present study, but kinetics analyses revealed that the initial amplitude of V̇O 2 was increased 388 during exercise at 85% P peak after nitrate supplementation. Nitrate supplementation resulted in a 389 faster τ and a substantially greater rate constant (amplitude/τ; ~73% increase). These findings are 390 in agreement with the speeding of pulmonary V̇O 2 kinetics shown during whole body exercise in 391 instances of compromised O 2 delivery and/or recruitment of higher order Type II muscle fibers 392 (3, 6, 31, 32) and the equivalent microvascular PO 2 response in rats (23). The present 393 investigation is the first to show significant differences in kinetics parameters after an acute 394 dosage of nitrate, where other studies used chronic supplementation to see effects (3, 6, 31) . 395
However, these improvements in V̇O 2 amplitude and speed of adjustment did not lead to 396 improved T lim in the present investigation. Previous work has found that speeding V̇O 2 kinetics 397 during whole body exercise does not always result in improvements to T lim (10, 36), indicating 398 that the relationship between these two variables is not a simple relationship. Indeed, interactions 399 between V̇O 2 kinetics and other physiological parameters are likely requisite to see 400 improvements in exercise tolerance. Had there been a summation of the improved kinetics across 401 multiple transitions (such as that seen during daily activity), a greater sparing of the O 2 deficit 402 could result in an accumulated improvement. 403
404
Limitations 405
We acknowledge that the method used to estimate V̇O 2 herein utilizes several 406 assumptions (7) and likely overestimated the V̇O 2 . We contend that these assumptions, held 407 constant throughout, should not obscure an impact of nitrate on V̇O 2 . Additionally, our sample 408 size was small and as such could have resulted in the present investigation not being sufficiently 409 powered to detect differences in some variables (e.g., exercising MAP and VC). Finally, we did 410 not measure plasma [nitrite] in all nine subjects (access to the NOA was precluded during later 411 data collection); however, the three subjects without this measurement exhibited similar 412 differences in blood pressure to the six with plasma [nitrite] measurements. It should be noted 413 that no pre-dose blood pressure measurements were made in the present investigation. However, 414 each subject served as their own control and thus had two separate days of blood pressure 415 measurements for each condition (i.e., nitrate and placebo), increasing our confidence that nitrate 416 influenced blood pressure herein. 417
418
Conclusions 419
The present study reaffirmed previous findings that an acute dose of nitrate is associated 420 with lower SBP, DBP, and MAP in healthy, young men. The acute dose was also an effective 421 method to increase and speed the local muscle V̇O 2 on-kinetics parameters during severe 422 intensity handgrip exercise, primarily through an increased fractional O 2 extraction rather than 423 increased blood flow. However, the ergogenic effects associated with nitrate supplementation 424 (i.e., improved tolerance to exercise) during large muscle mass exercise were not seen when the 425 exercise was performed in small muscle mass handgrip exercise. Values are expressed as means ± SE. * significantly different from placebo within work rate, † significantly different from 40% P peak within supplement (both p < 0.05).
Analysis completed on 7 of 9 subjects. at the end of each minute of 85 %P peak exercise and at the limit of exercise tolerance (T lim 
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